A role for insulin as a risk factor has been proposed for BPH, and several studies have examined components of metabolic syndrome (MetabS) in the pathogenesis of BPH and LUTS, which have been reviewed elsewhere [12,33,35]. The gene discussed is INS; the disease is benign prostatic hyperplasia.